| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | $4,8100 | +0,00 % | $621,31M | $820,25K | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | $15,8200 | -0,06 % | $620,51M | $921,16K | |
EIKN Eikon Therapeutics, Inc. Common Stock | $11,3700 | -0,18 % | $619,88M | $532,79K | |
| $18,9600 | +0,00 % | $619,48M | $360,50K | |
| $59,4800 | +0,07 % | $618,62M | $75,23K | |
EMD Western Asset Emerging Markets Debt Fund, Inc | $10,6500 | +0,47 % | $618,50M | $131,91K | |
CBNK Capital Bancorp, Inc. | $36,5400 | +0,03 % | $617,08M | $72,57K | |
NRDS NerdWallet, Inc. Class A Common Stock | $9,8700 | -0,10 % | $616,85M | $1,09M | |
| $71,5200 | -0,27 % | $616,57M | $178,20K | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | $43,0000 | -0,26 % | $615,50M | $527,97K | |
CGNT Cognyte Software Ltd. Ordinary Shares | $8,5900 | -0,12 % | $613,97M | $928,77K | |
BWB Bridgewater Bancshares, Inc. Common Stock | $21,6000 | -0,14 % | $613,72M | $187,98K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $9,5300 | +0,11 % | $613,18M | $63,54K | |
ELMT The Elmet Group Co. Common Stock | $19,8500 | -0,18 % | $612,93M | $1,74M | |
| $7,0600 | +1,15 % | $611,79M | $713,44K | |
